Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
INTERCOAT
- Development stage
- Unknown
- Lead developer
- FzioMed
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Intrauterine (local Application During Surgery)
01
Overview
INTERCOAT is a bioresorbable gel formulation, also known as Oxiplex/AP Gel, designed to reduce the formation of adhesions following intrauterine surgical procedures. It acts as a physical barrier that separates tissue surfaces during the critical wound healing period, thereby minimizing post-surgical adhesion formation. The product is primarily used in gynecological surgeries such as hysteroscopic or other intrauterine interventions to prevent intrauterine adhesions (Asherman’s syndrome). Its mechanism of action is mechanical—providing a temporary barrier rather than exerting pharmacological effects[2].
- Brand names
- INTERCOAT
- Other names
- Oxiplex/AP Gel
Beyond the preview
Go deeper on INTERCOAT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INTERCOAT.